ORDER
REPRINTS
166
RILEY AND GRINDLEY
bined organic extracts were dried (MgSO4), concentrated, and the residue purified
by flash chromatography on silica gel (eluant ethyl acetate: hexanes 1:2) to give the
title compound (Rf, 0.65) as a colorless syrup (0.068 g, 50 %): [ꢀ]D ꢁ22.3° (c 0.9,
1
dichloromethane); H NMR: ꢃ 0.11 (d, 2 ꢇ 3H, Si(CH3)2 ), 0.91 (d, 9H,
SiC(CH3)3), 3.52 ( broad dt, 1H, J4,5 ꢅ 10.38, J5,6 ꢅ J5,6ꢆ ꢅ 2.59 Hz, H-5), 3.78
(broad t, 1 H, J3,4 ꢅ J4,5 ꢅ 8.54 Hz, H-4), 3.92 (broad s, 2H, H-6,6ꢆ), 5.16 (t,1H,
J
1,2 ꢅ J2,3 ꢅ10.22 Hz, H-2) 4.35 (t, 1H, J3,4 ꢅ J2,3 ꢅ 8.85 Hz, H-3), 4.43, 4.78 (2d,
2H, Jꢅ 12.05 Hz, OCH2Ph), 4.77, 4.86 (2d, 2H, J ꢅ 10.99 Hz, OCH2Ph), 5.51 (d,
1H, J1,2 ꢅ 10.23 Hz, H-1), 7.2–7.6 (4m, 19H, 2CH2Ph, SPh, Npth): 13C NMR: ꢃ
ꢂ4.9 (SiC(CH3)3) 26.0 (SiC(CH3)3), 29.7 (SiC(CH3)3), 54.9 (C2), 61.5 (C3), 62.1
(C6), 72.1, 75.0 (2 OCH2Ph), 79.0 (C4), 80.2 (C5), 83.1 (C1), 127.4, 127.8, 128.0,
128.4, 128.5, 128.8, 132.7, (2 CH2Ph, SPh, Npth), 138.2, 138.4(2 CO, Npth).
General Method for De-O-benzylation: Phenyl 2,4,6-Tri-O-pivaloyl-1-
thio-ꢄ-D-galactopyranoside (2b). Compound 2a (0.100 g, 0.16 mmol) was dis-
solved in carbon tetrachloride (10 mL) and water (5 mL). NBS (2.5 equiv, 0.049 g,
0.276 mmol ) was then added, followed by calcium carbonate (4.4 equiv, 0.072 g,
0.716 mmol). The solution was then purged with nitrogen for one hour. Using a
375 W incandescent light, the reaction mixture was irradiated for 15 min while be-
ing monitored by TLC. The mixture was then poured into water (25 mL) and ex-
tracted with dichloromethane (3 ꢇ 30 mL). The combined organic extracts were
dried (MgSO4), concentrated, and the residue was purified by flash chromatogra-
phy on silica gel using ethyl acetate: hexanes 1:5 as eluant, to give the title com-
pound (0.081 g, 95%) as a colorless syrup (Rf, 0.23). The product was crystallized
from hexane to give fine colorless needles: mp 105–106°C; [ꢀ]D ꢂ5.0° (c 1.2,
chloroform); 1H NMR: ꢃ 1.27, 1.20 (2s, 3 ꢇ 9H, 3 C(CH3)3 ), 3.91 (m, 2H, H-3,
H5), 4.12 (m, 2H, H-6,6ꢆ), 4.70 (d, 1H, J1,2 ꢅ 10.07 Hz, H-1), 4.92 (t, 1H, J1,2
ꢅ J2,3 ꢅ 9.76 Hz, H-2), 5.32 (br dd, 1H, J3,4 ꢅ 3.35 Hz, J4,5 ꢅ 0.9, H-4), 7.2–7.6
(m, 5H, SPh); 13C NMR: ꢃ 27.1 (3 C(CH3)3), 38.7, 38.9, 39.2 (3 C(CH3)3), 62.1
(C-6), 69.5 (C-4), 70.2 (C-2), 73.0, 74.9 (C-3, C-5), 8.6 (C-1), 128.3, 128.9, 131.9,
133.2, (SPh), 178.0, 178.1, 178.6 (3 OCO); EIMS m/z: 524 (0.1%, Mꢁ), 509(0.1%,
M-Me), 415(100%, M-SPh); HRMS for C27H40O8S: Calcd 524.2444. Found:
524.2437.
2,4,6-Tri-O-pivaloyl-ꢄ-D-galactopyranosyl Fluoride (3b). Compound
3a (0.229 g, 0.56 mmol) was reacted as outlined for compound 2a to give the title
compound (0.187 g, 87%) as a colorless syrup: Rf, 0.50 (ethyl acetate: hexanes
1:5); [ꢀ]D ꢁ52.5° (c 3.9, dichloromethane); 1H NMR: ꢃ 1.20, 1.28, 1.29 (3s, 3 ꢇ
9H, 3 C(CH3)3 ), 4.11 (d, 2H, H-6,6ꢆ), 4.28 (dd, 1H, J3,4 ꢅ 3.36 Hz, J2,3 ꢅ 10.37
Hz, H-3), 4.37 (br t, 1H, J5,6 ꢅ J5,6ꢆ ꢅ 6.72 Hz, H-5), 4.98 (ddd, 1H, J1,2 ꢅ 2.60
Hz, J2,3 ꢅ10.38 Hz, J2,F ꢅ 24.42 Hz, H-2), 5.44 (br d, 1 H, J3,4 ꢅ 3.36 Hz, H-4),
5.63, 5.84 (2d, 1H, J1,2 ꢅ 2.89, J1,F ꢅ 53.86 Hz, H-1); 13C NMR: ꢃ 27.1, 27.2, 27.4
(3 C(CH3)3), 38.9, 39.2, 39.5 (3 C(CH3)3), 61.4 (C-6), 67.0 (C-3), 69.5 (2C, C-4,
C-5), 70.5 (d, 2JC,F ꢅ 23.8 Hz, C-2), 104.8 (d, 1JC,F ꢅ 227.7 Hz, C-1),178.1, 178.4,
178.9 (3 OCO); EIMS m/z: 434 (not observed, Mꢁ), 414 (7.6%, Mꢁ - HF), 399